logo
Plus   Neg
Share
Email

Moderna Concludes Advanced Discussions With European Commission On Supply Of COVID-19 Vaccine

Moderna, Inc. (MRNA) announced the company has concluded advanced exploratory talks with the European Commission to supply 80 million doses of mRNA-1273, the company's COVID-19 vaccine candidate. The potential purchase agreement provides for an option for Member States to purchase an additional 80 million doses for a total of up to 160 million doses.

Stphane Bancel, CEO of Moderna, said: "We are scaling up our international manufacturing capacity outside of the United States with our strategic partners, Lonza in Switzerland and Rovi in Spain, to be in a position to address this global health emergency with a vaccine that is widely available once approved for use."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter Inc. on Friday unlocked the New York Post's Twitter account after a two-week stalemate over posting links to its reporting about Hunter Biden. Walmart has removed guns and ammunition from its store shelves in the U.S. as a precautionary measure following the unrest in Philadelphia after a Black man was fatally shot by police, according to reports. While the firearms will be available for purchase at the Walmart stores, customers will be required to specifically request for them. Regeneron Pharmaceuticals Inc. (REGN) said Friday that the independent data monitoring committee or IDMC for the REGN-COV2 antibody cocktail treatment trials for COVID-19 has recommended to hold further enrollment in hospitalized patients requiring high-flow oxygen or mechanical ventilation.
Follow RTT